Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 311

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo

Parsons, C.G., Quack, G., Bresink, I., Baran, L., Przegalinski, E., Kostowski, W., Krzascik, P., Hartmann, S., Danysz, W.·1995·Neuropharmacology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/0028-3908(95)00092-k

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 57

  1. Andine, 1991, Intra- and extracellular changes of amino acids in the cerebral cortex of the neonatal rat during hypoxic ischemi, Dev. Brain Res., 64, 155, 10.1016/0165-3806(91)90214-4 · doi:10.1016/0165-3806(91)90214-4
  2. Benveniste, 1984, Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis, J. Neurochem., 43, 1369, 10.1111/j.1471-4159.1984.tb05396.x · DOI · Paper page
  3. Buisson, 1992, Striatal protection induced by lesioning the substantia-nigra of rats subjected to focal ischemia, J. Neurochem., 59, 1153, 10.1111/j.1471-4159.1992.tb08358.x · DOI
  4. Chen, 1992, Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity, J. Neurosci., 12, 4427, 10.1523/JNEUROSCI.12-11-04427.1992 · DOI · Paper page
  5. Clements, 1992, The time course of glutamate in the synaptic cleft, Science, 258, 1498, 10.1126/science.1359647 · DOI · Paper page
  6. Collingridge, 1990, Excitatory amino acid receptors and synaptic plasticity, Trends Pharmac. Sci., 11, 290, 10.1016/0165-6147(90)90011-V · DOI · Paper page
  7. Danysz, 1988, Learning impairment in rats by N-methyl-D-aspartate receptor antagonists, Neuropharmacology, 27, 653, 10.1016/0028-3908(88)90189-X · DOI · Paper page
  8. Danysz, 1994, Are NMDA antagonistic properties relevant for antiparkinsonian activity in rats? Case of amantadine and memantine, J. Neural Transm.—Parkinsons Sect., 7, 155, 10.1007/BF02253435 · DOI
  9. Danysz, 1995, Glutamate in CNS disorders — a revived target for drug development?, Drug News & Perspectives, 8, 261
  10. Dansyz, 1995, Modulation of learning processes by ionotropic glutamate receptor ligands, Behav. Pharmac.
  11. Dimpfel, 1995, Effects of memantine on synaptic transmission in the hippocampus in vitro, Arzneim. Forsch./Drug Res., 45, 773
  12. Ditzler, 1991, Efficacy and tolerability of memantine in patients with dementia syndrome, Arzneim. Forsch./Drug Res., 41, 773
  13. Erdö, 1991, Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and,N-methyl-D-aspartate, Eur. J. Pharmac., 198, 215, 10.1016/0014-2999(91)90625-Z · DOI
  14. Foster, 1987, The novel anticonvulsant (+)-MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain, Br. J. Pharmac., 91, 403, 10.1111/j.1476-5381.1987.tb10295.x · DOI · Paper page
  15. Globus, 1991, Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat, J. Neurochem., 57, 470, 10.1111/j.1471-4159.1991.tb03775.x · DOI · Paper page
  16. Görtelmeyer, 1992, Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study, Arzneim. Forsch./Drug Res., 42, 904
  17. Grant, 1992, Comparison of the effects of the uncompetitive N-methyl-D-aspartate antagonist (+ / −)- 5 — aminocarbonyl -10,11- dihydro — 5H — dibenzo (c, d — cyclo — hepten-5, 10-imine (ADCI) with its structural analogs dizocilpine ((+)-MK-801) and carbamazepine on ethanol withdrawal seizures, J. Pharmac. Exp. Ther., 260, 1017
  18. Hashimoto, 1994, Dopamine has inhibitory and accelerating effects on ischemia-induced neuronal cell damage in the rat striatum, Brain Res. Bull., 33, 281, 10.1016/0361-9230(94)90195-3 · DOI
  19. Herron, 1986, Frequency-dependent involvement of NMDA receptors in the hippocampus: a novel synaptic mechanism, Nature, 322, 265, 10.1038/322265a0 · DOI · Paper page
  20. Jackisch, 1994, The antiparkinsonian drugs budipine and biperiden are use-dependent (uncompetitive) NMDA receptor antagonists, Eur. J. Pharmac., 264, 207, 10.1016/0014-2999(94)00528-1 · DOI
  21. Johnson, 1987, Glycine potentiates the NMDA response in cultured mouse brain neurons, Nature, 325, 529, 10.1038/325529a0 · DOI · Paper page
  22. Keilhoff, 1992, Memantine prevents quinolinic acid-induced hippocampal damage, Eur. J. Pharmac., 219, 451, 10.1016/0014-2999(92)90487-O · DOI
  23. Kemp, 1987, Non-competitive antagonists of excitatory amino acid receptors, Trends Pharmac. Sci., 10, 294
  24. Kornhuber, 1991, Effects of the 1 -amino-adamantanes at the (+)-MK-801-binding site of the NMDA-receptor-gated ion channel—a human postmortem brain study, Eur. J. Pharmac., 206, 297, 10.1016/0922-4106(91)90113-V · DOI · Paper page
  25. Kornhuber, 1994, Amantadine and memantine are NMDA receptor antagonists, J. Neural Transm. -Gen. Sect., 43, 91
  26. Leander, 1988, N-methyl-D-aspartate acid-induced lethality in mice: selective antagonism by phencyclidine-like drugs, Brain Res., 448, 115, 10.1016/0006-8993(88)91107-9 · DOI
  27. Leppik, 1988, MK-801 for epilepsy: a pilot study, Neurology, 38, 405
  28. Litchfield, 1949, A simple method of evaluating dose-effect experiments, J. Pharmac. Exp. Ther., 96, 99
  29. Lodge, 1990, Noncompetitive excitatory amino acid receptor antagonists, Trends Pharmac. Sci., 11, 81, 10.1016/0165-6147(90)90323-Z · DOI · Paper page
  30. Löscher, 1990, High doses of memantine (l-amino-3,5-dimethyladamantane) induce seizures in kindled but not in non-kindled rats, Naunyn-Schmiedbergs Arch. Pharmac., 341, 476
  31. Löscher, 1994, Over-additive anticonvulsant effect of memantine and NBQX in kindled rats, Eur. J. Pharmac., 259, R3, 10.1016/0014-2999(94)90514-2 · doi:10.1016/0014-2999(94)90514-2
  32. Luby, 1959, Study of a new schizophrenomimetic drug: Sernyl, Arch. Neurol. Psychiat., 81, 363, 10.1001/archneurpsyc.1959.02340150095011 · DOI · Paper page
  33. Lysko, 1992, Neuroprotective effects of carvedilol, a new antihypertensive, at the N-methyl-D-aspartate receptor, Neurosci. Lett., 148, 34, 10.1016/0304-3940(92)90798-C · DOI
  34. Mayer, 1984, Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurons, Nature, 309, 261, 10.1038/309261a0 · DOI · Paper page
  35. Meldrum, 1986, Anticonvulsantaction of l,3-dimethyl-5-aminoadamantane. Pharmacological studies in rodents and baboon, Papio Papio, Naunyn-Schmiedbergs Arch. Pharmac, 332, 93, 10.1007/BF00633204 · doi:10.1007/bf00633204
  36. Misztal, 1994, Learning impairment induced by chronic intraventricular infusion of quinolinic acid—a model of progressive excitotoxicity, Behav. Pharmac., 5, 55
  37. Mitani, 1992, Selective vulnerability of hippocampal CA1 neurons cannot be explained in terms of an increase in glutamate concentration during ischemia in the gerbil: Brain microdialysis study, Neuroscience, 48, 307, 10.1016/0306-4522(92)90492-K · DOI
  38. Nowak, 1984, Magnesium gates glutamate-activated channels in mouse central neurons, Nature, 307, 462, 10.1038/307462a0 · DOI · Paper page
  39. Nozawa, 1993, The neuroprotective properties of ES-242s, novel NMDA receptor antagonists, in neuronal cell culture toxicity studies, Eur. J. Pharmac., 236, 263, 10.1016/0014-2999(93)90597-B · doi:10.1016/0014-2999(93)90597-b
  40. Palmer, 1992, Biological profile of the metabolites and potential metabolites of the anticonvulsant remacemide, Epilepsy Res., 12, 9, 10.1016/0920-1211(92)90086-9 · doi:10.1016/0920-1211(92)90086-9
  41. Pantev, 1993, Clinical and behavioural evaluation in long-term care patients with mild to moderate dementia under Memantine treatment, Zeitschr. Gerontol. Psychiat., 6, 103
  42. Parsons, 1993, Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1- amino-3,5-dimethyladamantan), Neuropharmacology, 32, 1337, 10.1016/0028-3908(93)90029-3 · DOI · Paper page
  43. Parsons, 1994, Comparative studies on NMDA receptor antagonism by amantadine (1-amino-adamantane) and memantine (1-amino-3,5-dimethyladamantane), Soc. Neurosci. Abstr., 20, 1144
  44. Rho, 1994, Mechanism of action of the anticonvulsant felbamate—opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acid, receptors, Ann. Neurol., 35, 229, 10.1002/ana.410350216 · DOI · Paper page
  45. Rogawski, 1992, The NMDA receptor, NMDA antagonists and epilepsy therapy, Drugs, 44, 279, 10.2165/00003495-199244030-00001 · DOI · Paper page
  46. Rogawski, 1993, Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines, Trends Pharmac. Sci., 14, 325, 10.1016/0165-6147(93)90005-5 · DOI · Paper page
  47. Rogawski, 1990, Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds, Pharmac. Rev., 42, 223
  48. Seif el Nasr, 1990, Neuroprotective effect of memantine demonstrated in vivo and in vitro, Eu. J. Pharmac., 185, 19, 10.1016/0014-2999(90)90206-L · DOI · Paper page
  49. Stieg, 1993, Post-stroke neuroprotection by memantine minimally affects behaviour and does not block LTP, Neurosci. Abstr., 19, 1503
  50. Sveinbjornsdottir, 1993, The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy, Epilepsy Res, 16, 165, 10.1016/0920-1211(93)90031-2 · DOI · Paper page
  51. Urbanska, 1992, Antiparkinsonian drugs memantine and trihexyphenidyl potentiate the anticonvulsant activity of valproate against maximal electroshock-induced seizures, Neuropharmacology, 31, 1021, 10.1016/0028-3908(92)90103-V · doi:10.1016/0028-3908(92)90103-v
  52. Weller, 1993, NMDA receptor-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: neuroprotective properties of amantadine and memantine, Brain Res., 613, 143, 10.1016/0006-8993(93)90464-X · DOI
  53. Wenk, 1994, Investigations of neuroprotection within the nucleus basalis of the rat, Brain Res., 655, 7, 10.1016/0006-8993(94)91590-3 · DOI
  54. Wenk, 1995, MK-801, memantine and amantadine show potent neuroprotective activity against NMDA toxicity in the nucleus basalis—a dose response study, Eur. J. Pharmac., 10.1016/0926-6917(95)00028-3 · DOI
  55. Willets, 1990, The behavioural pharmacology of NMDA receptor antagonists, Trends Pharmac. Sci., 11, 423, 10.1016/0165-6147(90)90150-7 · DOI · Paper page
  56. Williams, 1991, Modulation of the NMDA receptor by polyamines, Life Sci., 48, 469, 10.1016/0024-3205(91)90463-L · DOI · Paper page
  57. Wong, 1988, [3H](+)-MK-801 labels a site on the N-methyl-d-aspartate receptor channel complex in rat, J. Neurochem., 50, 274, 10.1111/j.1471-4159.1988.tb13260.x · DOI · Paper page

Cited by

See all 311

Metadata

Authors
Parsons, C. G., Quack, G., Bresink, I., Baran, L., Przegalinski, E., Kostowski, W., Krzascik, P., Hartmann, S., & Danysz, W.
Venue
Neuropharmacology
Publisher
Elsevier BV
Published
1995-10
Volume
34
Issue
10
Pages
1239-1258
ISSN
0028-3908 (ISSN-L)
OpenAlex
W2020789218
Cited by
311
References
2
FWCI
5.08
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. https://app.cochat.ai/papers/10.1016/0028-3908(95)00092-k
The paper
Parsons, C. G., Quack, G., Bresink, I., Baran, L., Przegalinski, E., Kostowski, W., Krzascik, P., Hartmann, S., & Danysz, W. (1995). Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology. https://doi.org/10.1016/0028-3908(95)00092-k

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.